Andreas Gerber
Geschäftsführer bei APEIRON Biologics AG
Ursprung des Netzwerks ersten Grades von Andreas Gerber
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
APEIRON Biologics AG
APEIRON Biologics AG BiotechnologyHealth Technology APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria.
8
| Holding Company | Biotechnology | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Andreas Gerber
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
BAYER AG | Pharmaceuticals: Major | General Counsel | |
SEQUENOM, INC. | Medical Specialties | Chairman | |
2INVEST AG | Financial Conglomerates | Director/Board Member | |
CoreOptics GmbH
CoreOptics GmbH Electronic Production EquipmentElectronic Technology Founded in 2001, CoreOptics develops and manufactures 10G and 40G Distortion Tolerant MSA Modules and IC solutions for ultra high-speed optical networking applications in the telecommunications and information technology industries. The company believes that optical communications networks must become open systems that economically transmit information regardless of data rate or fiber type. By building optical networks upon the only working MLSE-based transponders on the market today, CoreOptics is leading the way in providing advanced analog and digital signal processing remedies for the physical layer impairments. CoreOptics has received financing from leading venture capital firms, including T-com, GIMV, Crescendo Ventures, TVM, High Tech Private Equity, Atila Ventures, Quest for Growth and others. The CoreOptics team includes highly-skilled engineers with extensive experience in RF and digital ASIC design, as well as optical systems, applications and network architecture. The firm with operations in Nuremberg and Stuttgart, Germany and San Jose, California/Manchester New Hampshire, USA, develops and manufactures subsystems for ultra high-speed optical networking applications in the telecommunications and information technology industries. | Electronic Production Equipment | Director of Finance/CFO | |
CONCERT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Medical Specialties | Director/Board Member | |
GSK PLC | Pharmaceuticals: Major | General Counsel | |
TVM Capital GmbH
TVM Capital GmbH Investment ManagersFinance TVM Capital GmbH (TVMC) is an international venture capital firm headquartered in Munich, Germany. Founded in 1983, the firm was formerly known as Techno Venture Management. | Investment Managers | Chairman | |
MEDIGENE AG | Biotechnology | Director of Finance/CFO | |
Knoll AG
Knoll AG Pharmaceuticals: MajorHealth Technology Part of BASF SE, Knoll AG develops pharmaceuticals. The company is based in Haren, Germany. | Pharmaceuticals: Major | General Counsel | |
Wellington Partners GmbH
Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Investment Managers | Private Equity Investor | |
Vienna University of Economics & Business | College/University | Doctorate Degree | |
BIOFRONTERA AG | Pharmaceuticals: Major | Chairman | |
HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Director of Finance/CFO | |
ENANTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Roland Berger GmbH
Roland Berger GmbH Miscellaneous Commercial ServicesCommercial Services Roland Berger GmbH provides business consulting services. It offers advisory services to international enterprises and public institutions on business management issues ranging from rule-breaking strategies to organizational structures and business processes. The firm focuses on corporate development, information management, marketing and sales, operations strategy, restructuring and corporate finance. Roland Berger was founded on September 14, 1998 and is headquartered in Munich, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
SelectX Pharmaceuticals, Inc.
SelectX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SelectX Pharmaceuticals, Inc. engages in the discovery and development of aminoglycoside therapeutics for unmet medical needs. Its advanced program, development candidate SXP2523, is a next generation aminoglycoside antibiotic for drug resistant gram-negative hospital-acquired infections (HAIs); SXP2523 possesses broad spectrum coverage with potency against Pseudomonas, Klebsiella, Acinetobacter, E. coli, and Staphylococcus. The company was founded by Michael G. Chaparian and Charles R. Cantor in 2002 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Hoerbiger Holding AG
Hoerbiger Holding AG Industrial MachineryProducer Manufacturing Hoerbiger Holding AG engages in the manufacture and sale of compressors, engines, and turbomachines. The firm’s products include reciprocating compressors, engine service products, gas engines, rotary compressors, industrial explosion protection, valve automation, mechanical engineering, medical technology, passenger cars and light commercial vehicles, commercial vehicles, automotive test systems, and loading comfort. It also offers reciprocating compressor, engine, industrial engine, turbomachinery, as well as wellhead compression services. The company was founded in 1895 and is headquartered in Zug, Switzerland. | Industrial Machinery | Director/Board Member | |
Eberhard Karls Universität Tübingen | College/University | Doctorate Degree | |
Philipps University of Marburg | College/University | Graduate Degree | |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | General Counsel | |
Müller Dairy (UK) Ltd.
Müller Dairy (UK) Ltd. Food: Meat/Fish/DairyConsumer Non-Durables Müller Dairy (UK) Ltd. sells diary products. The company's diary products include, Müllerice, Raspberry and Apple 6 pack, Müllerlight, Blackcurrant, Müllerlight Drink and Müllerlight Three New McVities. Müller Dairy was founded in 1986 and is headquartered in Market Drayton, UK. | Food: Meat/Fish/Dairy | Chief Executive Officer | |
Graz University of Technology | College/University | Corporate Officer/Principal | |
The World Economic Forum USA, Inc.
The World Economic Forum USA, Inc. Miscellaneous Commercial ServicesCommercial Services The World Economic Forum USA, Inc. operates an organization for economic reforms. The non-profit company is based in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
European Private Equity & Venture Capital Association | Chairman | ||
AMECO MEDICAL INDUSTRIES | Medical Specialties | Director/Board Member | |
TVM Capital Healthcare Partners Ltd.
TVM Capital Healthcare Partners Ltd. Investment ManagersFinance TVM Capital Healthcare Partners Ltd (TVM Capital Healthcare Partners) is a private equity subsidiary of TVM Capital GmbH founded in 2009. It is headquartered in Dubai, UAE. | Investment Managers | Chief Executive Officer | |
ProVita International Medical Center LLC
ProVita International Medical Center LLC Hospital/Nursing ManagementHealth Services ProVita International Medical Center LLC provides health care services. It offers continued care services such as rehabilitative therapies, social and cultural development, social and cultural integration. The company was founded by Christina Shawky on 2011 and is headquartered in Abu Dhabi, the United Arab Emirates. | Hospital/Nursing Management | Chief Executive Officer | |
HELIOVIS AG
HELIOVIS AG Electric UtilitiesUtilities HELIOVIS AG develops solar concentrator for large solar power plants. Its product is HELIOtube, a novel type of solar concentrator for large solar power plants which mainly consists of plastic foils. The firm also develops a disruptive-innovative approach that shall find a permanent place in the expansion of solar energy at locations with intensive direct solar radiation. The company was founded by Johannes Hoefler and Felix Tiefenbacher in 2009 and is headquartered in Wiener Neudorf, Austria. | Electric Utilities | Director/Board Member | |
Catherex, Inc.
Catherex, Inc. Miscellaneous Commercial ServicesCommercial Services Catherex, Inc. provides medical research services. The company was founded by Michael A. Christini and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Director/Board Member | |
Bourn Hall International Ltd.
Bourn Hall International Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Bourn Bioscience Ltd., Bourn Hall International Ltd. provides management services. The company is based in Limassol, Cyprus. Founded in 2009. | Miscellaneous Commercial Services | Director/Board Member | |
Granzer Regulatory Consulting & Services | Chief Executive Officer | ||
Wilex, Inc.
Wilex, Inc. Medical/Nursing ServicesHealth Services Part of Nuclea Biotechnologies, Inc., Wilex, Inc. develops medical diagnostic tests. The company is based in Cambridge, MA. The CEOs of the company are Thomas Borcholte, Olaf G. Wilhelm. Wilex was acquired by Nuclea Biotechnologies, Inc. from Heidelberg Pharma AG on September 06, 2013. | Medical/Nursing Services | Director of Finance/CFO | |
Max-Planck-Innovation GmbH
Max-Planck-Innovation GmbH Miscellaneous Commercial ServicesCommercial Services Max-Planck-Innovation GmbH provides technology transfer from the research institutes. It offers technology transfer, patenting, licensing and start-up solutions. The company was founded in 1971 and is headquartered in Munich, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
Cambridge Medical & Rehabilitation Centre
Cambridge Medical & Rehabilitation Centre Hospital/Nursing ManagementHealth Services Cambridge Medical & Rehabilitation Centre provides healthcare, rehab, and admission services. It provides individualized non-acute long-term care and therapies to patients who need post-hospital medical and rehabilitative treatment at intermediate or intensive levels of care. The firm also offers individualized non-acute medical, nursing, rehabilitation and social services to treat and support each of its residents, including a range of rehabilitation programs for residents who recover from an injury or illness. The company was founded in 2012 and is headquartered in Abu Dhabi, United Arab Emirates. | Hospital/Nursing Management | Chairman | |
Manzil Health Care Services LLC
Manzil Health Care Services LLC Medical/Nursing ServicesHealth Services Manzil Health Care Services LLC provides home care services for adult and pediatric patients. It offers nursing care services, medical care and supporting medical care services and rehabilitation on intermediate and intensive level. The company was founded by Ghuwaya Al-Neyadi in 2011 and is headquartered in Abu Dhabi, United Arab Emirates. | Medical/Nursing Services | Chairman | |
Hewlett-Packard GmbH (Austria) | Corporate Officer/Principal | ||
Acceleration Partners LLC
Acceleration Partners LLC Advertising/Marketing ServicesCommercial Services Acceleration Partners LLC provides digital strategy and marketing services. It creates customized customer acquisition programs for individual consumer and e-commerce companies. The firm also specializes in organic search, paid marketing and site structures. The company was founded by Robert S. Glazer in 2007 and is headquartered in Needham, MA. | Advertising/Marketing Services | Founder | |
SHIELD THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Pharmaceuticals: Major | Director/Board Member | |
F-Star Beta Ltd.
F-Star Beta Ltd. BiotechnologyHealth Technology F-Star Beta Ltd. is a biopharmaceutical company that focused in the development of oncology and immune-oncology products. The company was founded on October 14, 2014 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
IMMUNOCORE HOLDINGS PLC | Biotechnology | Director/Board Member | |
invIOs Holding AG | Chief Executive Officer | ||
Biotechnologie-Industrie-Organisation Austria | Chief Executive Officer |
Statistik
International
Deutschland | 22 |
Vereinigte Staaten | 9 |
Österreich | 9 |
Vereinigtes Königreich | 6 |
Vereinigte Arabische Emirate | 5 |
Sektoral
Health Technology | 21 |
Commercial Services | 9 |
Finance | 5 |
Consumer Services | 5 |
Health Services | 5 |
Operativ
Director/Board Member | 31 |
Chairman | 14 |
Chief Executive Officer | 9 |
Director of Finance/CFO | 6 |
Corporate Officer/Principal | 5 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Andreas Gerber
- Unternehmensverbindungen